Amarin Corp Plcuk Liquidation Value

AMRN Pharmaceuticals

Cash & Equivalents

$131.06M
As of 2026-03-31
Current Price: $14.56 (as of 2026-05-18)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $131.06M
Total Obligations: -$192.93M
$-61.87M
Per share: $-0.15
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $131.06M
AR: $108.05M
Total Obligations: -$192.93M
$46.18M
Per share: $0.11
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $131.06M
AR: $108.05M
Inventory: $183.59M
Total Obligations: -$192.93M
$229.77M
Per share: $0.55
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-61.87M$-0.15
Liquid Liquidation Value$46.18M$0.11
Operating Liquidation Value$229.77M$0.55

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-04-29. View on SEC EDGAR →

Cash & Equivalents$131.06M
Accounts Receivable$108.05M
Inventory$183.59M
Current Liabilities$179.64M
Long-term Debt (?)$0
Op. Lease Liability (?)$5.58M
Finance Lease (?)N/A
Shares Outstanding419.6M

Explore all 112 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$131.06M$108.05M$183.59M$48.15M$179.64M$0$5.58MN/A
2025-12-31$134.66M$126.83M$195.91M$45.35M$194.46M$0$6.08MN/A
2025-09-30$122.80M$127.31M$184.70M$36.71M$182.23M$0$6.73MN/A
2025-06-30$147.88M$119.13M$171.24M$44.71M$185.95M$0$7.34MN/A
2025-03-31$119.52M$106.73M$159.49M$45.66M$162.41M$0$7.94MN/A
2024-12-31$121.04M$122.28M$166.05M$40.37M$179.95M$0$7.72MN/A
2024-09-30$156.94M$112.64M$224.00M$40.51M$201.55M$0$8.21MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-04-29 View
2025-12-31 10-K 2026-03-02 View
2025-09-30 10-Q 2025-10-29 View
2025-06-30 10-Q 2025-07-30 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-03-12 View
2024-09-30 10-Q 2024-10-30 View
2024-06-30 10-Q 2024-07-31 View

AI Insights

AI Insight·Generated 2026-05-05

Amarin Corporation (AMRN) presents a mixed but net-positive liquidation posture as of March 31, 2026, driven primarily by a large cash and short-term investment pool offset by a structurally oversized inventory position. Aggregate liquid assets (cash $131.1M, short-term investments $176.8M, net AR $108.1M) sum to approximately $416M at or near face value under liquidation assumptions. Against this, total liabilities stand at $196.4M at face value, with the current portion ($179.6M) dominated by accounts payable ($48.2M) and accrued liabilities. The company carries zero financial debt, which is a meaningful positive asymmetry in the liability stack. The MFFAIS operating liquidation value of $237.5M reflects the going-concern contribution of the inventory and AR base. The cash liquidation value of -$54.2M reflects the liability burden relative to the most conservative asset set (cash and equivalents alone). The liquid liquidation value of approximately $53.9M represents the residual after applying standard haircuts to current assets and settling all liabilities at face. The most significant liquidation risk is the $183.6M inventory balance, of which 65% is approved only for non-U.S. markets and thus faces materially lower realizability. At a 60% recovery rate, inventory yields roughly $110M, not book value. On the liability side, a $189M unconditional purchase obligation (supply chain commitments) does not extinguish on windup and is tagged in XBRL—this is a critical contingent liability that would crystallize in full in a liquidation scenario and is not reflected in the $196M total liabilities figure on the balance sheet. Including this obligation at face, effective liquidation liabilities approach $385M, which erodes the apparent positive recovery materially. Intangible assets ($12.7M net book value) receive zero recovery under the liquidation lens; they are not separately discussed as impaired in this period. Restructuring reserve ($5.2M) and other noncurrent liabilities ($11.1M) must be settled in full. The operating lease liability ($7.7M) does not extinguish; undiscounted payments total $9.6M through 2030. The Recordati partnership (June 2025) has restructured the European commercial operation, shifting it to a royalty model and eliminating direct European headcount, which has reduced the SG&A run rate from $36.6M to $21.1M QoQ and improved operating cash flow from -$12.5M to +$6.4M. This cost reduction is not a liquidation-value event but does reduce the rate of cash consumption. The deferred tax asset position is fully reserved (valuation allowance effectively eliminates it from liquidation recovery). No goodwill exists on the balance sheet. The accumulated deficit of $1.717B is a balance sheet artifact and does not affect liquidation recovery arithmetic directly.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...